Almac Clinical Technologies Named One of the 'Best Places to Work in PA 2009'
Yardley, PA
Almac Clinical Technologies announced that it has been named one of the Best Places to Work in PA for 2009. The awards program, created in 2000, is one of the first statewide programs of its kind in the country. It consists of a public/private partnership between Team Pennsylvania Foundation, the Pennsylvania Department of Community and Economic Development, the Pennsylvania Chamber of Business and Industry and the Central Penn Business Journal.
This survey and awards program was designed to identify, recognize and honor the best places to be employed in Pennsylvania. It is intended to acknowledge companies that have established a dynamic and productive working environment for their employees.
Companies from across the state entered the two-part process to determine the 100 Best Places to Work in PA. The first part consisted of evaluating each nominated company's workplace policies, practices, philosophies, systems and demographics. The second part consisted of an employee survey to measure the employee experience. The combined scores of both parts determined the top companies and the final ranking. Best Companies Group managed the overall registration and survey process.
Almac Clinical Technologies will be recognized at the Best Places to Work in PA evening awards ceremony on Tuesday, December 1, 2009, at the Hershey Lodge & Convention Center in Hershey, PA. Rankings will be revealed at the ceremony.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.
